Close Menu

NEW YORK – Lucira Health, a startup formerly known as Diassess, announced today it has closed a $15 million Series B equity financing round.

The Emeryville, California-based developer of instrument-free, molecular diagnostics for infectious disease testing intends to use the funds to finance regulatory clearances and early commercialization.

The funding was led by Seraph Group with participation from Eclipse Ventures, DCVC (Data Collective), Y Combinator, Sunstone Management, and ShangBay Capital, the firm said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.